These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23605376)

  • 1. Nephrectomy for the failed renal allograft in children: predictors and outcomes.
    Minson S; Muñoz M; Vergara I; Mraz M; Vaughan R; Rees L; Olsburgh J; Calder F; Shroff R
    Pediatr Nephrol; 2013 Aug; 28(8):1299-305. PubMed ID: 23605376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Allograft Nephrectomy on Second Renal Transplant Outcome.
    Muramatsu M; Hyodo Y; Sheaff M; Gupta A; Ashman N; Aikawa A; Yaqoob M; Puliatti C
    Exp Clin Transplant; 2018 Jun; 16(3):259-265. PubMed ID: 29676700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy.
    Del Bello A; Congy-Jolivet N; Sallusto F; Guilbeau-Frugier C; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Blancher A; Rostaing L; Kamar N
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1310-9. PubMed ID: 22626959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of circulating antibodies in a renal transplantation population: preliminary results.
    Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F
    Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney retransplantation: removal or persistence of the previous failed allograft?
    Dinis P; Nunes P; Marconi L; Furriel F; Parada B; Moreira P; Figueiredo A; Bastos C; Roseiro A; Dias V; Rolo F; Macário F; Mota A
    Transplant Proc; 2014; 46(6):1730-4. PubMed ID: 25131023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.
    Immenschuh S; Zilian E; Dämmrich ME; Schwarz A; Gwinner W; Becker JU; Blume CA
    Transplantation; 2015 Jan; 99(1):56-62. PubMed ID: 25121474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
    Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
    Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience.
    Gheith O; Al-Otaibi T; Halim MA; Mahmoud T; Nair P; Monem MA; Al-Waheeb S; Hassan R; Nampoory N
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):150-155. PubMed ID: 28260457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-Year Analyses of Renal Graft Biopsies: A Single-Center Pathology Experience.
    Canpolat T; Ozdemir BH; Torun D; Caliskan K; Haberal M
    Exp Clin Transplant; 2017 Apr; 15(2):171-178. PubMed ID: 27099951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.